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Research
Secondhand smoke (SHS) is the combination 
of smoke given off by the burning end of a 
tobacco product and the smoke exhaled by 
the smoker. The Germany National Health 
Survey 1998 estimated a prevalence of 55% 
for regular exposure to SHS in nonsmokers 
18–79 years of age in Germany (Deutsches 
Krebsforschungszentrum 2005). Exposure to 
SHS is a relevant health problem; for exam-
ple, cardiovascular event rates are 20–50% 
higher in subjects exposed to SHS than in 
those not exposed, causing an estimated 
40,000–50,000 deaths from coronary heart 
disease (CHD) in the United States each year 
(U.S. Department of Health and Human 
Services 2006). Biological mechanisms pro-
posed to explain adverse effects of SHS on the 
cardiovascular system include the elicitation 
of oxidative stress, inflammatory responses, 
activation of platelets, endothelial dysfunc-
tion, and changes of the autonomic balance 
(Barnoya and Glantz 2005).
Studies focusing on clinical events can-
not distinguish between the triggering of acute 
events and chronic processes leading to the 
development and progression of atherosclerosis 
as the underlying pathology for cardiovascular 
events. It is therefore necessary to investigate 
measures of subclinical atherosclerosis to assess 
the potential influence on the underlying dis-
ease process. Some studies suggest that SHS 
contributes to the development and progres-
sion of atherosclerosis. Recent studies found 
associations between SHS and carotid artery 
intimal-medial thickness (Knoflach et al. 
2009), aortic plaque (Kiechl et al. 2002), 
ankle-brachial index (He et al. 2008), arterial 
stiffness (Mack et al. 2003), and endothelial 
function (Leone and Balbarini 2008) as indica-
tors of subclinical atherosclerosis, but not all 
studies are consistent with a positive associa-
tion (Agarwal 2009). Whether SHS is associ-
ated with coronary atherosclerosis has not yet 
been investigated. Coronary artery calcifica-
tion/calcium (CAC) detected by electron-beam 
computed tomography is a reliable measure 
of the degree of coronary atherosclerosis and 
is associated with cardiac events (Erbel et al. 
2010; Folsom et al. 2008; Greenland et al. 
2007). The aim of the present study was to 
investigate the association of exposure to SHS 
and the degree of CAC as a measure of coro-
nary atherosclerosis in participants of a popula-
tion-based cohort in Germany.
Materials and Methods
Study population. We investigated baseline 
data from an ongoing prospective population-
based Caucasian cohort study in Germany 
(Heinz Nixdorf Recall Study). Details about 
design (Schmermund et al. 2002) and about 
baseline recruitment and population-based 
assessment of subclinical atherosclerosis 
(Schmermund et al. 2006) have been previ-
ously reported. In short, baseline data from 
4,814 participants 45–75 years of age were 
collected from 2000 to 2003. The original 
cohort aims to clarify the predictive value 
of coronary calcification for future cardiac 
events in a random population sample. We 
used baseline data from 1,766 never-  smokers 
(34% men) with available information on 
exposure and outcome (Figure 1). Data from 
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Ba c k g r o u n d: Secondhand smoke (SHS) consists of fine particulate matter, carcinogens, and 
  various toxins that affect large parts of the population. SHS increases the risk for acute cardio­
vascular events and may contribute to the development of atherosclerosis.
oBjectives: We investigated the association of SHS with coronary artery calcification (CAC).
Me t h o d s : In this cross­sectional analysis, we used baseline data (2000–2003) from 1,766 never­
  smokers without clinically manifested coronary heart disease, 45–75 years of age, from the Heinz 
Nixdorf Recall Study, an ongoing, prospective, population­based cohort study in Germany. Self­
reported frequent SHS at home, at work, and in other places was assessed by questionnaire. CAC 
scores were derived based on electron­beam computed tomography. We conducted multiple linear 
regression analysis using exposure to SHS as the explanatory variable and ln(CAC+1) as the response 
variable. We conducted logistic regression to estimate the odds ratio (OR) for presence of any CAC.
re s u l t s: Frequent exposure to SHS was reported by 21.5% of participants. After adjustment for 
age, sex, and socioeconomic status, CAC + 1 was 21.1% [95% confidence interval (CI): –5.5%, 
55.2%] higher in exposed than in unexposed participants. After adjusting for other cardiovascular 
risk factors, the association was attenuated (15.4%; 95% CI: –9.6%, 47.2%). SHS exposure was 
also associated with a CAC score > 0 (fully adjusted OR = 1.38; 95% CI: 1.03, 1.84).
co n c l u s i o n s: Self­reported frequent exposure to SHS was associated with subclinical coronary 
atherosclerosis in our cross­sectional study population. Considering the widespread exposure and the 
clinical relevance of coronary atherosclerosis, this result, if confirmed, is of public health importance.
key w o r d s : cardiovascular atherosclerosis, comparative risk assessment, environmental epi­
demiology, population health, secondhand smoke. Environ Health Perspect 119:1556–1561 
(2011).  http://dx.doi.org/10.1289/ehp.1003347 [Online 8 July 2011]SHS exposure and CAC among nonsmokers
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128 participants with clinically manifested 
CHD (previous myocardial infarction or cor-
onary revascularization) were excluded from 
the main analysis. The study protocol was 
approved by the local institutional review 
board of the University Hospital of Essen, 
and all participants gave written informed 
consent before the study.
Exposure assessment. Exposure to SHS 
at the time of the baseline examination was 
assessed in a computer-aided personal interview: 
“Do you frequently stay in rooms where people 
smoke at work, at home, or at other places?” 
and “How many persons live and smoke in 
your home including yourself?” We constructed 
an exposure variable regarding exposure to SHS 
at any place (yes/no) combining information 
about the three possible locations of exposure 
and also evaluated SHS exposure according to 
location. Objective quantification of exposure 
time was not provided.
Outcome assessment. Coronary athero-
sclerosis was investigated through an assess-
ment of the degree of CAC by electron-beam 
computed tomography (EBCT) (Greenland 
et al. 2007). The person who performed and 
interpreted the CAC results was blinded to 
participants’ characteristics, including SHS 
status. Noncontrast-enhanced EBCT was per-
formed with a C-150 scanner (GE Imatron, 
South San Francisco, CA, USA) (Schmermund 
et al. 2006). The scanner was operated in the 
single-slice mode with an image acquisition 
time of 100 msec and a section thickness of 
3 mm. Prospective electrocardiogram trig-
gering was done at 80% of the R-R interval. 
Contiguous slices down to the apex of the 
heart were obtained. The CAC score was 
determined using the method of Agatston 
et al. (1990). An area of CAC was defined as 
at least four contiguous pixels with a computer 
tomography density ≥ 130 Hounsfield units. 
The total CAC score was computed compris-
ing all calcified lesions in the epicardial coro-
nary system. Analyses were performed using 
a Virtuoso workstation (Siemens Medical 
Solutions, Forchheim, Germany).
Risk factor assessment. The baseline assess-
ment included a self-administered question-
naire, a computer-aided personal interview for 
personal risk factor assessment [family history 
of cardiovascular disease, history of hyperten-
sion and diabetes, smoking history, medica-
tions, socioeconomic status (SES)], laboratory 
tests, anthropometric measurements (weight, 
height), and a physical examination accord-
ing to a standard protocol, including the stan-
dardized measurement of brachial artery blood 
pressure. Current medications were coded 
according to the Anatomical Therapeutic 
Chemical Classification Index (World Health 
Organization Collaborating Centre for Drug 
Statistics Methodology 2005). Diabetes mel-
litus was defined as a prior physician diagnosis 
of diabetes, current use of antidiabetic drugs, 
random  blood  glucose  ≥  11  mmol/L 
(≥ 200 mg/dL), or having fasting blood glu-
cose ≥ 7 mmol/L (≥ 126 mg/dL) at the time 
of baseline examination. We used informa-
tion from self-reported medical history of 
such measurements. Information relevant to 
individual-level SES included formal education 
[categorized into four categories, with the high-
est ≥ 18 years (equivalent to a university degree) 
and the lowest ≤ 10 years (equivalent to a basic 
school degree and no vocational training)] and 
employment status (full-time or part-time work 
of ≥ 15 hr/week, inactive or housewife, pen-
sioner, and unemployed). Leisure time physical 
activity was assessed by questionnaire and con-
verted into weekly metabolic equivalents, which 
were included as a continuous variable.
Statistical analysis. Analyses were performed 
on the subgroup of never-  smokers (n = 1,766) 
with available information on CAC, SHS expo-
sure, age, sex, length of education, employment 
status, and other important cardio  vascular risk 
factors [diabetes mellitus, body mass index 
(BMI), physical activity, and ratio of low- to 
high-density lipoprotein (LDL:HDL)]. We 
conducted unadjusted and multiple linear 
regression analysis with exposure to SHS at 
any place (yes, no) as the explanatory variable. 
For these analyses, CAC scores were trans-
formed to normalize the distribution by using 
ln(CAC + 1) as the response variable. The rela-
tive effect of SHS exposure is given as percent 
change in CAC + 1 associated with any expo-
sure versus none. We used a directed acyclic 
graph, also known as causal diagram, to iden-
tify confounders and factors that may represent 
intermediate steps in the causal path (Glymour 
and Greenland 2008; Greenland et al. 1999; 
Shrier and Platt 2008). We concluded that age, 
sex, years of education, and employment were 
necessary covariates, which we used for adjust-
ment in the main model. We also adjusted for 
other factors, including potential intermediates 
in extended models, such as cardiovascular risk 
factors diabetes mellitus, BMI, physical activ-
ity, and LDL:HDL, as important predictors 
of CAC. Because the simultaneous adjustment 
for SES variables and cardiovascular risk fac-
tors that are also related to SES can lead to an 
overadjustment, we conducted this analysis as 
an additional step.
Because SHS exposure might exert its 
effect on subclinical atherosclerosis through 
an increase in blood pressure, we included 
systolic blood pressure and antihypertensive 
medication in a separate step.
To identify the most important location 
of SHS exposure, we included exposure to 
SHS at home, at work, and at other places as 
separate indicator variables in one model. This 
analysis was repeated after limiting the study 
population to participants < 66 years of age. 
In addition, we created indicator variables 
representing increasing exposure to SHS (no 
exposure as reference, exposure only at home, 
and exposure at home plus exposure at work 
or other places). To visualize the age- and 
sex-specific difference between exposed and 
nonexposed subjects, we stratified the regres-
sion analysis by exposure status (any SHS or 
no SHS) and plotted predicted CAC over age 
in both exposure groups. Separate graphs were 
generated for men and women, analogous 
Figure 1. Definition of study population.
Participants recall study 
n = 4,814
Never smoker 
n = 2,013
Available exposure and outcome data 
n = 1,904
No manifest coronary heart disease 
n = 1,766
No exposure to SHS 
n = 1,387
Excluded 
n = 109
Missing values: CAC, n = 68; SHS n = 1; other 
variables, n = 50
Excluded 
n = 2,801
Smoking status: current smoker, n = 1,211;
former smoker, n = 1,578; missing value, n = 12
Excluded 
n = 128
Manifest coronary artery disease, n = 128
Exposure to SHS 
n = 379
Home, n =169; at work, n = 213; other, n = 106Peinemann et al.
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to our prior analysis of the effect of smoking 
cessation on CAC (Jöckel et al. 2009).
To estimate the effect of SHS on the 
prevalence of any calcification (CAC > 0), we 
used logistic regression to derive odds ratios 
(ORs) for CAC > 0. In addition, we investi-
gated the effect of using different CAC score 
cut points for defining the dichotomous out-
come variable, from CAC > 0 versus CAC = 0, 
CAC > 1 versus CAC ≤ 1, and so forth, up 
to CAC > 1,000 versus CAC ≤ 1,000, and 
repeated the logistic regression analysis with 
these different response variables. As a further 
sensitivity analysis, we used ln(CAC + 0.1) 
and ln(CAC + 10) as the response variable in 
addition to ln(CAC + 1) in linear regression 
models. We also estimated the percent 
change in CAC associated with SHS in an 
analysis restricted to those with measurable 
CAC (n = 1,150) and estimated associations 
between SHS and prevalent diagnosed CHD 
at baseline (128 cases among 1,894 partici-
pants). All statistical analyses were conducted 
using SAS software (version 9.2; SAS Institute 
Inc., Cary, NC, USA).
Results
Self-reported frequent exposure to any SHS 
was reported by 21.5% of 1,766 never-
  smokers (Figure 1) and varied considerably by 
age and sex, as shown by a lower median age 
and higher percentage of men in the exposed 
group (Table 1). CAC was also strongly asso-
ciated with age and sex (Table 2). In the age-
stratified analyses, SHS-exposed participants 
generally had higher CAC values and frequen-
cies of CAC > 0 than did nonexposed par-
ticipants. In the full cohort of never-  smokers 
(n = 1,894), which included 128 participants 
with manifested CHD, CHD was more 
prevalent among participants reporting SHS 
exposure (33 of 412, 8.0%) than in those 
unexposed (95 of 1,482, 6.4%).
In linear regression analyses, the unadjusted 
crude estimate [–18.6%; 95% confidence inter-
val (CI): –38.0%, 7.0%] indicated an inverse 
association of SHS with CAC + 1 (Table 3). 
After adjusting for age, sex, years of education, 
and economic activity, CAC + 1 was 21.1% 
(95% CI: –5.5%, 55.2%) higher in exposed 
than in unexposed participants. Further adjust-
ment for the cardiovascular risk factors diabetes 
mellitus, BMI, physical activity, and LDL:HDL 
attenuated the association (15.4%; 95% CI: 
–9.6%, 47.2%). Additional adjustment for 
potential intermediate variables hypertension 
and antihypertensive therapy decreased the esti-
mate to 10.6% (95% CI: –14.3%, 42.7%). 
When limiting the analysis to subjects with 
CAC > 0 (n = 1,150), we did not see an associa-
tion with SHS (data not shown).
In logistic regression analysis, the OR for 
CAC > 0 was 1.47 (95% CI: 1.11, 1.94), 
adjusted for sex, age, years of education, and 
employment status, and 1.38 (95% CI: 1.03, 
1.84) after also adjusting for diabetes, BMI, 
physical activity and LDL:HDL (Table 3). 
Adding the potential intermediate variables 
hypertension and antihypertensive therapy to 
the model decreased the OR to 1.30 (95% 
CI: 0.97, 1.74). Using different cut-points for 
dichotomizing CAC in a secondary analysis 
revealed that CAC > 0 versus CAC = 0 up to 
CAC > 10 versus CAC ≤ 10 had ORs with 
lower 95% confidence limits > 1.0 (data not 
shown). Cut-points between CAC > 20 versus 
CAC ≤ 20 and CAC > 800 versus CAC ≤ 800 
resulted in positive effect estimates but with 
95% CIs including 1.0.
A linear regression model that included 
indicator variables for all three possible 
Table 1. Baseline characteristics of analyzed never-smokers (n = 1,766) in the Heinz Nixdorf Recall Study 
according to SHS exposure status.
Baseline characteristic SHSa (n = 379) No SHS (n = 1,387) Total (n = 1,766)
CACb
Mean 120.9 171.5 160.06
50th percentile (median) 7.0 7.7 7.7
75th percentile 56.2 99.0 88.7
Maximum value 4,790.3 5,636.3 5,636.3
Values > 0 [n (%)] 248 (66.4) 902 (65.0) 1,150 (65.1)
Age [years (median)] 57.0 63.0 62.0
BMI [kg/m2 (median)] 27.6 27.2 27.3
Physical activity, metabolic equivalents per week (median) 579.2 593.6 591.6
LDL [mg/dL (median)]  146.0 144.0 145.0
HDL [mg/dL (median)]  55.0 57.0 56.0
Systolic blood pressure [mmHg (median)] 131.5 131.5 131.5
Men [n (%)] 146 (38.5) 454 (32.7) 600 (34.0)
Diabetes mellitus [n (%)] 46 (12.1) 164 (11.8) 210 (11.9)
Antihypertensive drugs [n (%)]c 123 (32.5) 502 (36.2) 625 (35.4)
Length of education [n (%)]
≤ 10 years 62 (16.4) 212 (15.3) 274 (15.5)
11–13 years 216 (57.0) 761 (54.9) 977 (55.3)
14–17 years 70 (18.5) 260 (18.7) 330 (18.7)
≥ 18 years 31 (8.2) 154 (11.1) 195 (11.0)
Employment status [n (%)]
Full-time or part-time work (≥ 15 hr/week) 194 (51.2) 360 (26.0) 554 (31.4)
Inactive or housewife 54 (14.2) 318 (22.9) 372 (21.1)
Pensioner 103 (27.2) 639 (46.1) 742 (42.0)
Unemployed 28 (7.4) 70 (5.0) 98 (5.5)
No. of smokers at home [n (%)]d
0 203 (53.6) 1,284 (92.6) 1,487 (84.2)
1 151 (39.8) 96 (6.9) 247 (14.0)
≥ 2 25 (6.6) 7 (0.5) 32 (1.8)
Location of exposure
Home 1,597 169 1,766
Work 1,553 213 1,766
Other 1,660 106 1,766
aSelf-reported frequent exposure to SHS at work, at home, or at other places. bDetected by EBCT; mean CAC refers to 
the arithmetic mean in this population. cData missing for 116. dA total of 128 participants lived with a current smoker and 
reported no SHS at home; 18 participants reported SHS at home and did not live with a current smoker.
Table 2. Distribution of CAC among never-smokers without clinically manifested CHD (n = 1,766) according to age group and sex.
SHSa (n = 379) No SHS (n = 1,387) Total (n = 1,766)
Category n (%) P50 P75 CAC > 0 [n (%)] n (%) P50 P75 CAC > 0 [n (%)] n (%) P50 P75 CAC > 0 [n (%)]
Age group (years)
45 to < 55 143 (37.7) 1.0 17.5 73 (51.0) 286 (20.6) 0.0 7.2 118 (41.3) 429 (24.3) 0.0 12.4 191 (44.5)
55 to < 65 152 (40.1) 9.3 55.5 106 (69.7) 547 (39.4) 6.2 72.7 357 (65.3) 699 (39.6) 7.2 66.3 463 (66.2)
≥ 65 84 (22.2) 42.5 225.9 69 (82.1) 554 (39.9) 42.3 203.5 427 (77.1) 638 (36.1) 42.4 204.7 496 (77.7)
Sex
Men 146 (38.5) 36.2 157.6 125 (85.6) 454 (32.7) 49.7 247.8 362 (79.7) 600 (34.0) 47.7 205.9 487 (81.2)
Women 233 (61.5) 1.0 23.5 123 (52.8) 933 (67.3) 2.6 51.8 540 (57.9) 1,166 (66.0) 2.1 44.4 663 (56.9)
Abbreviations: P50, 50th percentile (median); P75, 75th percentile.
aSelf-reported frequent exposure to SHS either at work, at home, or at other places.SHS exposure and CAC among nonsmokers
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exposure locations plus age, sex, education, 
and employment status showed a stronger 
association between increased CAC + 1 and 
SHS exposure at home (34.1%; 95% CI: 
–5.0%, 89.3%) than exposure at work (7.1%; 
95% CI: –22.8%, 48.7%) or at other places 
(–7.6%; 95% CI: –39.4%, 40.9%). We 
found no clear exposure–response relation-
ship in the adjusted linear regression analy-
sis. Compared with the reference group (no 
exposure), exposure to SHS only at home and 
exposure to SHS at home plus exposure at 
work led to increases in CAC + 1 of 52.1% 
(95% CI: –3.0%, 118.1%) and 17.9% (95% 
CI: –28.1%, 93.4%), respectively. Restricting 
the analysis to participants < 66 years of age 
did not substantially influence results (data 
not shown). We chose this cutoff because 
legal entitlement to a pension is 65 years in 
Germany. In logistic regression, SHS at home, 
at work, and at other places was associated 
with presence of CAC with ORs of 1.21 (95% 
CI: 0.82, 1.78), 1.24 (95% CI: 0.87, 1.76), 
and 1.53 (95% CI: 0.93, 2.49), respectively.
We found no clear differences in asso-
ciations according to age or sex, but point 
estimates were generally stronger among men 
than among women (Table 3).
Figure 2, A and B, illustrates predicted 
CAC scores in men and women, respectively, 
according to age and exposure status. The pre-
dicted CAC score for a 45- to 54-year-old man 
with SHS exposure is comparable to the pre-
dicted CAC score for an unexposed man who 
is about 3 years older, whereas the predicted 
CAC score for an exposed man 65–74 years 
of age is comparable to the predicted score 
for an unexposed man who is about 1 year 
older. Women had much lower CAC scores 
than men at all ages, and we observed no clear 
association between SHS and predicted CAC 
score at any age.
In sensitivity analyses, the association 
between SHS and CAC score remained 
positive when we used ln(CAC + 0.1) and 
ln(CAC + 10) as dependent variables in linear 
regression. The age- and sex-adjusted OR for 
the association of SHS with clinically mani-
fested CHD was 1.48 (95% CI: 0.96, 2.26) 
and 1.43 (95% CI: 0.92, 2.22), respectively, 
with further adjustment for diabetes, BMI, 
physical activity, and LDL:HDL.
Discussion
This is the first study to examine exposure to 
SHS and CAC, a measure of subclinical ath-
erosclerosis that is highly predictive of future 
cardiovascular events (Erbel et al. 2010; Folsom 
et al. 2008; van der Meer et al. 2004). We used 
CAC = 0 versus CAC > 0 as dichotomous clas-
sification of coronary atherosclerosis in accor-
dance with other studies (Detrano et al. 2008; 
Greenland et al. 2004). We found that expo-
sure to SHS is associated with prevalence of 
CAC > 0 in never-  smokers. This association is 
robust to the inclusion of a variety of cardio-
vascular risk factors. Our results suggest that 
SHS may increase the risk of cardiovascular 
disease in part by influencing the underlying 
chronic process of coronary atherosclerosis, as 
has been suggested for ambient air pollution 
(Brook et al. 2010; U.S. Department of Health 
and Human Services 2006).
The observed association between SHS 
and CAC is primarily based on the contrast 
between no calcification and any detectable 
calcification. Different biological mechanisms 
could be responsible for the development of 
plaque, which encompasses earlier stages of 
atherosclerotic disease, than those leading to 
the progression of already existing calcified 
plaque in advanced atherosclerotic disease. 
Animal experiments support the role of SHS 
in early stages of atherosclerosis, showing a 
causal role of SHS in the development of 
atherosclerotic lesions (Knight-Lozano et al. 
2002). Exposure to SHS is associated with 
permanent inflammation and lipid accumu-
lation in blood vessels in mice (Yuan et al. 
2007) and in utero exposure results in an 
increased and earlier adult atherosclerotic 
lesion formation (Yang et al. 2007). Human 
studies have shown that the pathophysiology 
of SHS-induced cardiovascular toxicity 
includes arterial endothelial dysfunction, 
platelet activation, oxidation of low-density 
lipoprotein cholesterol, and increased insulin 
resistance, which are risk factors for athero-
sclerosis at early stages of the disease (Barnoya 
and Glantz 2005). The association between 
exposure to SHS and atherosclerosis might be 
initiated as early as during gestation (Geerts 
et al. 2008). Increased thickening of the coro-
nary walls has been observed in autopsies of 
fetuses of smoking mothers and of infants of 
smoking parents (Matturri et al. 2005).
Our inability to observe a linear associa-
tion of SHS with CAC in the subgroup of 
participants with more advanced coronary 
atherosclerosis, as manifested by presence of 
any CAC, might also be the result of an unfa-
vorable signal-to-noise ratio, with the con-
tribution of SHS to the progression of CAC 
being overshadowed by the increasing preva-
lence of other risk factors.
Atherosclerosis and hypertension are 
distinct but associated disease entities. The 
attenuation of associations between CAC and 
SHS after adjustment for blood pressure and 
antihypertensive medication is consistent with 
our assumption that high blood pressure may 
be an intermediate step in the causal pathway. 
Figure 2. Predicted CAC from multivariable regression of ln(CAC+1) on age and sex: men (A) and women 
(B). The diamonds represent the estimated difference in vascular age between SHS-exposed participants 
and unexposed participants.
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Table 3. Results of linear and logistic regression analysis.a
Linear regression model Logistic regression
Category Percent change in CAC+1b (95% CI) ORc (95% CI)
Unadjusted model for exposure to any SHS –18.6 (–38.0%, 7.0%) 1.02 (0.80, 1.29)
Model 1 (age, sex) 22.3 (–4.1%, 56.1%) 1.46 (1.12, 1.92)
Model 2 (age, sex, SES) 21.1 (–5.5%, 55.2%) 1.47 (1.11, 1.94)
45 to < 55 years of age 28.3 (–10.6%, 84.1%) 1.59 (1.01, 2.49)
55 to < 65 years of age 8.1 (–26.6%, 59.2%) 1.37 (0.89, 2.12)
≥ 65 years of age 21.4 (–29.4%, 108.6%) 1.41 (0.75, 2.64)
Men 27.8 (–16.5%, 95.7%) 1.96 (1.11, 3.44)
Women 16.0 (–14.6%, 57.6%) 1.33 (0.96, 1.85)
Model 3 (age, sex, SES, diabetes mellitus, BMI, 
physical activity, LDL:HDL)
15.4 (–9.6%, 47.2%) 1.38 (1.03, 1.84)
Model 4d (age, sex, SES) 21.1 (–6.5%, 56.8%) 1.41 (1.06, 1.89)
Model 5d (age, sex, SES, hypertension and 
antihypertensive therapy)
10.6 (–14.3%, 42.7%) 1.30 (0.97, 1.74)
SES comprises two covariates: years of education and employment status.
aAnalysis included 1,766 never-smokers without clinically manifested CHD for models 1–3 and 1,650 never-smokers for 
models 4 and 5. Manifested CHD includes previous myocardial infarction or coronary revascularization. bThe regression 
of ln(CAC + 1) can be converted to the percent change in CAC + 1 using the equation [(expβ – 1) × 100], where β is the 
change in ln(CAC + 1) associated with SHS exposure. cResponse variable of the logistic regression model: CAC > 0 (n = 
1,150) versus CAC = 0 (n = 616). dSmaller sample size (n = 1,650) because of missing values for antihypertensive therapy; 
response variable of the logistic regression model: CAC > 0 (n = 1,084) versus CAC = 0 (n = 566).Peinemann et al.
1560  v o l u m e  119 | n u m b e r 11 | November 2011  •  Environmental Health Perspectives
Endothelial dysfunction, reduction of vascular 
reactivity, and autonomic imbalance might be 
underlying physiologic pathways leading to 
an increase in blood pressure, although the 
exact mechanisms remain to be elucidated. A 
further potential mechanistic pathway is the 
elicitation of oxidative stress and the induc-
tion of a systemic inflammatory response, 
which are both related to atherogenesis and 
cardiovascular events (Libby et al. 2009).
The difference between the crude and 
adjusted estimates from the linear regression 
analysis is remarkable and can be explained by 
confounding by age, which is strongly associ-
ated with both exposure and outcome. We 
restricted covariates in the main model to vari-
ables that we defined a priori as necessary con-
founders based on a directed acyclic graph (sex, 
age, length of education, employment status). 
Adjusting for other cardiovascular risk factors 
attenuated the estimated percent change but 
did not markedly influence the OR for pres-
ence of CAC. Adjusting for SES may have 
reduced confounding due to factors such as 
antioxidant intake, which is related to SES.
Prior studies have examined the association 
of SHS with different morphologic markers 
of atherosclerosis, making direct comparisons 
across studies difficult. The size of the estimated 
effect in our study was comparable to a 3-year 
increase in vascular age in middle-age men, 
which represents a clinically relevant effect of 
SHS. In women and in the elderly, the effect 
on coronary age was diminished. As expected, 
the estimated effect was much smaller than the 
effect of active smoking (Jöckel et al. 2009).
One important limitation of this study is 
its small sample size, leading to an imprecise 
estimation of effects, manifesting as broad 
CIs. Even though the complete cohort con-
sists of almost 5,000 participants, we included 
only never-  smokers in the analysis of SHS 
exposure. Because the prevalence of smoking 
in Germany is still high, only 39% of the 
Heinz Nixdorf Recall Study participants were 
never-  smokers. Among these never-  smokers, 
only a relatively low proportion (22%) of par-
ticipants were considered exposed to SHS, 
in contrast to an estimated 55% exposure 
in the general adult population (Deutsches 
Krebsforschungszentrum 2005). This appar-
ent discrepancy can be explained by three fac-
tors: a) The type of SHS assessment required 
frequent exposure to SHS. b) Never-  smokers 
are a select population, socializing less with 
smokers compared with the general popula-
tion. c) We restricted our study population to 
the age range of 45–74 years, which does not 
include younger subjects with probable higher 
and more frequent SHS exposure.
The other major limitation of this study 
is the comparatively crude assessment of SHS 
exposure. The question whether participants 
“frequently stay in rooms where people smoke 
at work, at home, or at other places” may not 
clearly distinguish between an exposure that 
happened only recently and a life-long expo-
sure. Moreover, current exposure does not 
necessarily reflect long-term past exposure, 
and the validity of self-reported SHS expo-
sure in general may be compromised by poor 
recall. The lack of information on the exposure 
period and the average intensity of exposure to 
SHS prevented a more refined analysis of the 
exposure–response relationship and may have 
contributed to misclassification of exposure 
(Thun et al. 1999). However, non  differential 
misclassification of a binary exposure biases 
the effect toward the null. Therefore, the 
true size of the association might actually be 
higher than estimated in the present analyses. 
Although we did not take the specific type of 
occupation into consideration, some of which 
might be associated with dust exposure and 
SHS, we adjusted for educational attainment.
The lack of biomarker information such as 
urinary cotinine is not considered a major limi-
tation in this analysis, because coronary ath-
erosclerosis takes many years to develop and is 
not influenced by short-term exposure during 
the days before outcome assessment. However, 
biomarker information could have helped to 
validate self-reported smoking status and might 
have prevented the unintended inclusion of 
active smokers in the study population.
This study is a cross-sectional analysis and 
therefore does not allow direct conclusions 
regarding the development and progression of 
atherosclerosis. Future analyses in this cohort 
study with repeated measurements of CAC 
will investigate the progression of CAC in 
relation to SHS exposure.
Strengths of the study include the precise 
and reliable assessment of coronary athero-
sclerosis (CAC measured by EBCT) and the 
detailed and standardized assessment of car-
diovascular risk factors in a large population-
based cohort.
Conclusions
Self-reported frequent exposure to SHS was 
associated with subclinical coronary athero-
sclerosis in our cross-sectional study popula-
tion. Considering the widespread exposure 
and the clinical relevance of coronary athero-
sclerosis, this result, if confirmed, is of public 
health importance.
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